Post on 24-Mar-2020
PRIVATE AND CONFIDENTIAL
FEBRUARY 2020
TERRACEGLOBAL
DISCLAIMERThis presentation of Terrace Global Inc. (“Terrace" or the "Company”) is for information purposes only and shall not constitute an offer to buy, sell, issue or subscribe for, or the solicitation of
an offer to buy, sell or issue, or subscribe for any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The information contained herein is subject to change
without notice and is based on publicly available information, internally developed data and other sources. Where any opinion or belief is expressed in this presentation, it is based on the
assumptions and limitations mentioned herein and is an expression of present opinion or belief only. No warranties or representations can be made as to the origin, validity, accuracy,
completeness, currency or reliability of the information. Terrace disclaims and excludes all liability (to the extent permitted by law), for losses, claims, damages, demands, costs and expenses
of whatever nature arising in any way out of or in connection with the information in this presentation, its accuracy, completeness or by reason of reliance by any person on any of it. This
presentation should not be construed as legal, financial or tax advice to any individual, as each individual’s circumstances are different. Investors should consult with their own professional
advisors regarding their particular circumstances. The information contained in this presentation is not directed to persons or entities resident in the United States and does not constitute an
offer or solicitation by anyone in the United States or in any other jurisdiction in which such an offer or solicitation is not authorized or to any person to whom it is unlawful to make such an
offer or solicitation, unless otherwise exempt from United States securities legislation.
Forward-looking information
Certain statements in this presentation are “forward-looking statements”. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans,
projections, objectives, assumptions or future events or performance (often, but not always using words or phrases such as “expect”, “seek”, “endeavour”, “anticipate”, “plan”, “estimate”,
“believe”, “intend”, or stating that certain actions, events or results may, could, would, might or will occur or be taken, or achieved) are not statements of historical fact and may be “forward-
looking statements”. Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and un certainties
which would cause actual results or events to differ materially from those presently anticipated. Forward-looking statements are based on expectations, estimates and projec- tions at the
time the statements are made and involve significant known and unknown risks, uncertainties and assumptions. A number of factors could cause actual results, performance or achievements
to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. Should one or more of these risks or
uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance or achievements could vary materially from those
expressed or implied by the forward-looking statements contained in this document. Readers should not place undue reliance on these forward-looking statements. Although the forward-
looking statements contained in this presentation are based upon what Terrace currently believes to be reasonable assumptions, Terrace cannot assure readers that actual results,
performance, or achievements will be consistent with these forward-looking statements. Except as required by law, Terrace does not have any obligation to advise any person if it becomes
aware of any inaccuracy in or omission from any forward-looking statement, nor does it intend, or assume any obligation, to update or revise these forward-looking statements to reflect new
events or circumstances. The proposed directors and officers of Terrace will be appointed effective at the closing of the reverse takeover. The Company’s advisors and strategic partners are
already working with the Company.
2Private and confidentialwww.terraceglobal.ca
3
Terrace is a Canadian company focused on the development and
acquisition of international cannabis assets. Our single minded
goal is to unlock value in new jurisdictions.
Terrace was created by a group of pioneers in the cannabis space.
We’ve come together to build a best in class portfolio of assets,
across international markets. With decades of cross-continent
relationships between us, the Terrace team is uniquely positioned
to unlock value in new jurisdictions like no one else can.
About us.
Private and confidentialwww.terraceglobal.ca
4
InternationalAssets
Existing world class platform inUruguay, Spain and Portugalcovering recreational cannabis,
medical cannabis andhemp assets in low-cost jurisdictionswith progressive regulatory regimesand strong domestic demand.
GlobalRelationships
Our Management, Board, andAdvisors have a rich internationalbackground with influence globally.
We have worked, lived,and executed transactions
around the world,across capital markets, agriculture,and government regulations.
ExclusiveDeal Pipeline
We have sourced proprietarydeal flow from South America,Europe and other continents,and expect to be a global player
in the cannabis industry.
What we offer
Private and confidentialwww.terraceglobal.ca
5
Our strategy.Terrace’s operations will expand across Europe, South America,
and other continents, to become a leading dry flower
and derivatives producer globally.
Terrace has already secured production assets in
low-cost jurisdictions and maintains a proprietary deal pipeline
to acquire additional production capacity.
GLOBAL ASSETSTRATEGY
✓ Existing domestic market✓ Approved for exportation
✓ Low cost inputs
Private and confidentialwww.terraceglobal.ca
FRANCISCO ORTIZDIRECTOR
S P A I N - U R U G U A Y
MICHAEL GALEGO STEPHEN ARBIBDIRECTOR DIRECTOR
P O R T U G A L - U R U G U A YC O L O M B I A - B R A Z I L
I S R A E L - G E R M A N YN E T H E R L A N D S
VINCE GASPARRO DENIS MILLSDIRECTOR DIRECTOR
U S A - E U R O P E - I S R A E L U S A - E U R O P E - I S R A E L
Board of directors.
Entrepreneur andphilanthropist
Founder of MedReleaf,sold to Aurora
CEO, Momentum Solutions
Principal Secretary toToronto Mayor John ToryPrivate Equity Investor,Green Tomorrow Fund
PMO under PM Paul MartinMSc, London School of
Economics MBA, VillanovaUniversity
Corporate DirectorMember of CanadianParliament, CEO of MI
Developments,Directorships with FronteraEnergy, CGX Energy and
Hut-8 Mining
Lawyer & EntrepreneurCo-Founder and Director ofICC Labs, sold to Aurora
CEO of the Stronach Group,Agricultural DivisionM&A Lawyer at Osler,Hoskin & Harcourt LLP.
6
International Entrepreneur &Co-Founder of Tuenti, the“Spanish Facebook”, sold toTelefonica Co-Founder of
“Glass”, sold Glass Trademarkto Google. Bachelor Degreein Economics from Harvard
University.
Private and confidentialwww.terraceglobal.ca
FRANCISCO ORTIZ STEPHEN LERMERCEO COO/PRESIDENT
S P A I N - U R U G U A Y U S A - L A T A M
BENWEDEKINGHEAD OF CULTIVATION
I S R A E L - G E R M A N YN E T H E R L A N D S
JOHN CHOUCFO
C A N A D A - C O L O M B I A
Led cannabis projects in Israel(Tikun Olam), Germany, andNetherlands (Bedrocan).
BA in Agricultural Studies +Masters in Process and Quality
Management, HumboldtUniversity
Seasoned financial executive withextensive expertise in entrepreneurial
organizations and internationalfinancial management. PreviouslyVice President, Finance of Gran
Colombia Gold and Frontera Energy,and manager at Deloitte in Toronto.
CPA, CA. MBA.
Management team.
7
Reference BIOunder "Board of Directors"
Accomplished global pharmaceutical and
Cannabis executive with broad experience in
all aspects of product development,
industrialization and commercialization.
Experienced C-level manager and leader of
multi-disciplined teams through all phases of
company lifecycle. B.S. Mechanical
Engineering, M.S. Engineering, MBA.
Private and confidentialwww.terraceglobal.ca
8
International advisory board.
Former Minister,International Trade, Canada
Former Secretary of State,International FinancialInstitutions, Canada
International EntrepreneurCo-Founder, Tokyo Smoke / HIKUCo-Founder, PharmaCan Capital
Co-Founder, CannasatPharmaceuticals
Chairman and CEO, Hill & GertnerCapital
Entrepreneur and business builderPresident Stafford Developments,Co-Founder Autumn GrowthCo-Founder Cannoe Canada
Former Minister of Foreign Relations,Colombia
Former CEO,Gran Colombia Gold
Mª CONSUELO ARAUJOADVISOR
S O U T H A M E R I C A
HON. JAMES PETERSON LORNE GERTNERADVISOR ADVISOR
B R A Z I L - R U S S I AC H I N A - I N D I A - M I D D L E E A S T
JONATHAN GOLDMAN
A F R I C A - I S R A E LN O R T H A M E R I C A - E U R O P E
ADVISOR
Private and confidentialwww.terraceglobal.ca
9
GASTON MAGRI FRANCISCO GUTIERREZORANSUR PHARMABINOIDE
NUNO LAGESTERRA NOVA
P O R T U G A LU R U G U A Y S P A I N
Operations team.
Senior Agricultural Enginner Headof Production, Cibeles, Uruguay.
Degrees in Agriculture Engineeringfrom Stella Maris College,
Montevideo + Universidad de laRepublica, Montevideo
Economist & Entrepreneur.Founder of Pharmabinoide,Spanish Hemp Company.
Senior Private Banker at Citibankand Banco Santander.
Technical Director, ShirePharmaceuticals Ltd, PortugalTechnical Director, Udifar,
PortugalEMBA, University of Navarra
Private and confidentialwww.terraceglobal.ca
10
Strategic partner.
M A R I M E D OW N S6 % O F T E R R A C E .
MariMed Inc., a public company trading as MRMD:OTCQB, is a US multi state developer and operator of
medical and adult–use cannabis cultivation, production, and dispensary facilities. It is dedicated to
improving health and wellness with the highest quality cannabis and hemp-derived CBD products. The
company has recently announced the formation of a separate division, MariMed Hemp, focused on the
development of leading brands for its rapidly-growing CBD product family.
In late 2018, Marimed announced an investment in Kentucky- based GenCanna, industry leader in the
production of GMP-quality, highly regulation-compliant CBD products in the US.
Terrace will benefit from Marimed’s strategic relationship and significant investment in GenCanna, as
Marimed will be collaborating with Terrace.
Private and confidentialwww.terraceglobal.ca
Existing asset structure: South America and Europe
11
SpainUruguay100% of Pharmabinoide
Hemp
100 acres
33% of Faises*
Recreational Cannabis
3.7 acres
Portugal100% of Terra Nova
Medical Cannabis
10 acres
100% ofOransur*
Hemp
150 acres
*Shares subject to a call option in favour of Terrace
Private and confidentialwww.terraceglobal.ca
Uruguay: OransurOransur, S.A. leases farms from
across Uruguay to cultivate
various crops with proprietary
and imported genetics.Oransur’s first harvest in 2019
Greenhouse for Oransur High CBD Genetics
Combine Harvester
12
Our current operation is 150 acres and located in
Florida, Uruguay, with the ability to expand our
production area to 1,250 acres.
Private and confidentialwww.terraceglobal.ca
Private and confidentialwww.terraceglobal.ca 13
Uruguay: Faises
Faises has 1 of only 2
licenses in Uruguay to
produce and distribute
recreational cannabis.
RECREATIONAL CANNABIS LICENSE
Fully licensed to produce psychoactive
recreational cannabis for delivery and
distribution to approved pharmacies.
INCREASING CAPACITY
Current production at 2 tonnes/year, with
opportunity to increase to 4 tonnes per year.
COUNTRY-WIDE DISTRIBUTION EXPORTATION OPPORTUNITY
Distribution footprint includes all Uruguay,
with a current population of over 3 million
people.
Oppotunity to export outside of Uruguay
pending IRCCA apprval.
14
Pharmabinoide S.L. is a licensed producer of
hemp in Spain with approximately 100 acres of
hemp operations located in Jaen.
Pharmabinoide is in the process of being
accredited by the AEMPS to allow its products
to be certified for medical and research
purposes.
Spain.
AEMPS: Spanish Medicines and Health Products Agency
Private and confidentialwww.terraceglobal.ca
15
Terra Nova was official sponsor of Portugal’s first medical cannabisconference
Portugal.Terra Nova,Producao e Commercializacao
de Produtos Naturals e Farmaceuticos, LDA
is a Portuguese company, positioned to be a
leading European producer of medical
cannabis and industrial hemp.
In early 2016, Terra Nova applied for a
license to cultivate, import and export
cannabis Sativa L. License from our site in
Pinhal Novo, Palmela, Portugal.
In December 2018, INFARMED, I.P., the governing regulatory body in Portugal, issued a declaration (or "pre-license")
to Terra Nova permitting the construction of up to a 350,000 sq. ft. greenhouse and 2.5 acres of
outdoor cultivation.The final license to be issued upon final inspection by INFARMED of Terra
Nova’s facilities. The license will allow for cultivation, importation, and exportation of Cannabis
Sativa L.
Private and confidentialwww.terraceglobal.ca
16
Milestone timeline.Complete closing ofRTO and public listing
Complete acquisitionof Faises andimprovements atgreenhouse facility inUruguay
Second outdoor hempharvest in Spain
Second plantation ofoutdoor hemp inUruguay
Completion ofgreenhouse facility inPortugal
Second outdoor hempharvest in Spain
Completion of ethanolextraction lab inUruguay
NOV 2 0 1 9 Q 4 2 0 1 9 Q 4 2 0 1 9 Q 3 2 0 2 0 Q 3 2 0 2 0 Q 3 2 0 2 0Q 4 2 0 1 9
Private and confidentialwww.terraceglobal.ca
17
International opportunity.
State/Province conflictwith federal law
Medical law
Recreational law
According to Canopy Growth, the
Canadian medical cannabis market
is $3B, the Canadian recreational
market is $5-9B and the global
medical cannabis market is$180B.
Source: Ackrell Capital 2018 Cannabis Investment Report
SE LECT COUNTR I E S W I TH LEGAL I Z ED CANNAB I SACCE S S ( A S O F J AN 2 0 1 8 )
Private and confidentialwww.terraceglobal.ca
18
Peer group.C O M P A N Y E Q U I T Y V A L U E J U R I S D I C T I O N S S T A T U S
Pharmacielo
ICC Labs
Khiron Life Sciences
Scythian
Terrace
Holigen
Inverell
Cannapur
$350M
$320M
$100M
$193M
$80M
$30M
$25M
$17M
Colombia
Uruguay, Colombia
Colombia, Uruguay
Argentina, Colombia, Jamaica
Uruguay, Portugal, Spain
Portugal
Uruguay
Uruguay
Acquired by Aurora
Acquired by Aurora
Strategic investment by MariMed
Flowr Corp acquired 20% for $6M cash
Acquired by Auxly
Acquired by Khiron for $17M in shares
Private and confidentialwww.terraceglobal.ca
Use of proceeds.
19
Ethanol Extraction Plant (Uruguay) $1,500,000
Terra Nova Greenhouse (Portugal) $4,500,000
M&A Opportunities $6,500,000
G&A (18 months) $4,500,000
Total $17,000,000
Terrace is fully funded to complete the build out of its operations in
Uruguay, Spain and Portugal. The Company recently completed an over-
subscribed financing ($17M) and has approximately $20M in cash on hand.
Private and confidentialwww.terraceglobal.ca
20
Capitalization.
* 24.6 million shares are subject to a 6 month lock-up post closing of theRTO. Founders and management are subject to 3 year TSXV escrow.
E X I S T I NG SH A R EHO LD E R S
Management 67,765,000
Board of Directors 15,720,000
International Advisory Board 19,700,000
MariMed Inc. 10,734,400
Other Shareholders 53,421,556
Total 167,340,956
Private and confidentialwww.terraceglobal.ca
TERRACEGLOBAL
SPAINAv. Mercado, Edf. Don Angel, 29601,Marbella, Malaga.
URUGUAY25 de Mayo 555 of 21,Montevideo.
CANADA1133 Yonge Street, Suite 300,Toronto, Ontario, M4T 1W1.
www.terraceglobal.cainfo@terraceglobal.ca